Co-founder and CEO of Sibylla Biotech S.p.A.,
MBA in business innovation, Ph.D. in Physics, with
20+ years of experience in science and entrepreneurship. Lidia fostered the creation of the company and supported the corporate culture. She raised the seed and the Series A rounds, found, negotiated, and executed the collaboration contract with Takeda Pharmaceutical, and built the business and financial plan leading the company to fulfillment of objectives. Attention to the people and their engagement and welfare in the company is her major commitment.
MBA in business innovation, Ph.D. in Physics, with
20+ years of experience in science and entrepreneurship. Lidia fostered the creation of the company and supported the corporate culture. She raised the seed and the Series A rounds, found, negotiated, and executed the collaboration contract with Takeda Pharmaceutical, and built the business and financial plan leading the company to fulfillment of objectives. Attention to the people and their engagement and welfare in the company is her major commitment.
Speaking In
10:30 AM - 10:45 AM (EST)
Tuesday, February 7
Sibylla is an early-stage drug discovery company based on the enabling possibility of simulating…
Palace